| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |